856 related articles for article (PubMed ID: 36092161)
1. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and neurodegenerative diseases.
Fu YW; Xu HS; Liu SJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response.
Hsu PC; Shahed-Al-Mahmud M
Life Sci; 2022 Nov; 308():120981. PubMed ID: 36150465
[TBL] [Abstract][Full Text] [Related]
4. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.
Calderón-Garcidueñas L; Torres-Jardón R; Franco-Lira M; Kulesza R; González-Maciel A; Reynoso-Robles R; Brito-Aguilar R; García-Arreola B; Revueltas-Ficachi P; Barrera-Velázquez JA; García-Alonso G; García-Rojas E; Mukherjee PS; Delgado-Chávez R
J Alzheimers Dis; 2020; 78(2):479-503. PubMed ID: 32955466
[TBL] [Abstract][Full Text] [Related]
5. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
Szabo MP; Iba M; Nath A; Masliah E; Kim C
Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson's Disease.
Zhang J; Bishir M; Barbhuiya S; Chang SL
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686360
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19.
Naidu SAG; Wallace TC; Davies KJA; Naidu AS
J Diet Suppl; 2023; 20(2):218-253. PubMed ID: 33977807
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases.
Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M
Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
11. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia.
Barbieri MA; Bagnato G; Ioppolo C; Versace AG; Irrera N
CNS Neurol Disord Drug Targets; 2022; 21(10):1017-1026. PubMed ID: 35021982
[TBL] [Abstract][Full Text] [Related]
12. Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?
Rudnicka-Drożak E; Drożak P; Mizerski G; Zaborowski T; Ślusarska B; Nowicki G; Drożak M
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767513
[TBL] [Abstract][Full Text] [Related]
13. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM
Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387
[TBL] [Abstract][Full Text] [Related]
14. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
Chen F; Chen Y; Wang Y; Ke Q; Cui L
Transl Neurodegener; 2022 Sep; 11(1):40. PubMed ID: 36089575
[TBL] [Abstract][Full Text] [Related]
15. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Amadoro G; Latina V; Stigliano E; Micera A
Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
[TBL] [Abstract][Full Text] [Related]
17. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Parkinson's Disease: Possible Links in Pathology and Therapeutics.
Tiwari S; Yadav N; Singh S
Neurotox Res; 2022 Oct; 40(5):1586-1596. PubMed ID: 35829997
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
[TBL] [Abstract][Full Text] [Related]
20. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
Conte C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
